DG
72
4
AAL
48
-2
AVGO
45
3
CCL
82
-4
CNX
38
-3
CL
62
-2
AFL
45
-3
BF.B
33
-2
BK
72
-2
CA
36
12
DRI
58
-5
AES
57
2
CAT
69
11
DOV
71
10
CPB
39
2
C
81
-4
CHRW
76
-3
ALL
57
-3
AIZ
76
-2
AVY
50
3
DG
72
4
AAL
48
-2
AVGO
45
3
CCL
82
-4
CNX
38
-3
CL
62
-2
AFL
45
-3
BF.B
33
-2
BK
72
-2
CA
36
12
DRI
58
-5
AES
57
2
CAT
69
11
DOV
71
10
CPB
39
2
C
81
-4
CHRW
76
-3
ALL
57
-3
AIZ
76
-2
AVY
50
3
Financhill
Back

Davis Select US Equity ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
72

DUSA
Davis Select US Equity ETF

Last Price:
$52.00
Seasonality Move:
8.6%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$39.6600
Seasonality Move:
33.23%
Buy
72
Davis Select US Equity ETF (DUSA) is a Buy

Is Davis Select US Equity ETF a Buy, Sell or Hold?

  • The current Davis Select US Equity ETF [DUSA] share price is $52.03. The Score for DUSA is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • DUSA is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $39.6400. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DUSA Stock Price Chart

What is Davis Select US Equity ETF's stock price today?

  • The Davis Select US Equity ETF share price today is $52.03
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DUSA is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $39.6400
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight selling pressure.

DUSA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.75 Buy
Relative Strength Index (14 RSI): 68.99 Buy
Chaikin Money Flow: 19107 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.98 - 51.8) Buy
Bollinger Bands (100): (46.97 - 49.95) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 10.28 Buy
Relative Strength Index (14 RSI): 66.31 Buy
Chaikin Money Flow: -583105 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.9202 - 36.9202) Buy
Bollinger Bands (100): (20.9405 - 34.5405) Buy

DUSA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.42 Buy
20-day SMA: 51.01 Buy
50-day SMA: 49.3 Buy
200-day SMA: 46.1 Buy
8-day EMA: 51.53 Buy
20-day EMA: 50.85 Buy
50-day EMA: 49.7 Buy
200-day EMA: 46.84 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.31 Buy
20-day SMA: 35.4 Buy
50-day SMA: 33.69 Buy
200-day SMA: 22.3 Buy
8-day EMA: 30.99 Buy
20-day EMA: 18.54 Buy
50-day EMA: 8.93 Buy
200-day EMA: 2.46 Buy

Davis Select US Equity ETF Earnings Growth & DUSA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Davis Select US Equity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):